These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12660020)

  • 1. Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1H-dihydropyrrolizine type.
    Ulbrich H; Fiebich B; Dannhardt G
    Eur J Med Chem; 2002 Dec; 37(12):953-9. PubMed ID: 12660020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of a novel series of pyrrolizine derivatives as dual cyclooxygenase-1 and 5-lipoxygenase inhibitors.
    Laufer S; Striegel HG; Neher K; Zechmeister P; Donat C; Stolingwa K; Baur S; Tries S; Kammermeier T; Dannhardt G; Kiefer W
    Arch Pharm (Weinheim); 1997 Oct; 330(9-10):307-12. PubMed ID: 9396390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pyrrole moiety as a template for COX-1/COX-2 inhibitors.
    Dannhardt G; Kiefer W; Krämer G; Maehrlein S; Nowe U; Fiebich B
    Eur J Med Chem; 2000 May; 35(5):499-510. PubMed ID: 10889329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase.
    Rioja I; Terencio MC; Ubeda A; Molina P; Tárraga A; Gonzalez-Tejero A; Alcaraz MJ
    Eur J Pharmacol; 2002 Jan; 434(3):177-85. PubMed ID: 11779581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors.
    Sud'ina GF; Pushkareva MA; Shephard P; Klein T
    Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):99-108. PubMed ID: 18280718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
    Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
    Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of 3,4-diaryl-3-pyrrolin-2-one derivatives on cyclooxygenase 1 and 2 in murine peritoneal macrophages.
    Shen F; Bai AP; Guo ZR; Cheng GF
    Acta Pharmacol Sin; 2002 Aug; 23(8):762-8. PubMed ID: 12147201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase.
    Albert D; Zündorf I; Dingermann T; Müller WE; Steinhilber D; Werz O
    Biochem Pharmacol; 2002 Dec; 64(12):1767-75. PubMed ID: 12445866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studied on docking of 5,6-diaryl-2,3-dihydro-1-pyrrolizinone derivatives with cyclooxygenase].
    Zhao LQ; Hu YD; Yuan Y; Zhang T; Zhang SF; Li S
    Yao Xue Xue Bao; 2001 Jun; 36(6):415-8. PubMed ID: 12585123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of natural products containing acylresorcinol partial structures on cyclooxygenases and 5-lipoxygenase.
    Bracher F; Krauss J; Laufer S
    Pharmazie; 2001 May; 56(5):430. PubMed ID: 11400568
    [No Abstract]   [Full Text] [Related]  

  • 11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
    Fiorucci S; Meli R; Bucci M; Cirino G
    Biochem Pharmacol; 2001 Dec; 62(11):1433-8. PubMed ID: 11728379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro test system for the evaluation of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibitors based on a single HPLC run with UV detection using bovine aortic coronary endothelial cells (BAECs).
    Dannhardt G; Ulbrich H
    Inflamm Res; 2001 May; 50(5):262-9. PubMed ID: 11409489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.
    Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Chen J; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
    J Med Chem; 1998 Aug; 41(18):3515-29. PubMed ID: 9719605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
    Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
    Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monochloramine potently inhibits arachidonic acid metabolism in rat platelets.
    Fujimoto Y; Ikeda M; Sakuma S
    Biochem Biophys Res Commun; 2006 May; 344(1):140-5. PubMed ID: 16615995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-1/COX-2 inhibitors based on the methanone moiety.
    Dannhardt G; Fiebich BL; Schweppenhäuser J
    Eur J Med Chem; 2002 Feb; 37(2):147-61. PubMed ID: 11858847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal anti-inflammatory agents, Part 19. E-2-pyrrolizin-5-yl acrylic acids as potent dual or selective inhibitors of bovine cyclooxygenase and 5-lipoxygenase.
    Dannhardt G; Kiefer W; Nowe U
    Arch Pharm (Weinheim); 1995 Sep; 328(9):681-6. PubMed ID: 7487426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hinokitiol, a selective inhibitor of the platelet-type isozyme of arachidonate 12-lipoxygenase.
    Suzuki H; Ueda T; Juránek I; Yamamoto S; Katoh T; Node M; Suzuki T
    Biochem Biophys Res Commun; 2000 Sep; 275(3):885-9. PubMed ID: 10973816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.